Profile for Hungary Patent: S2200010

US Patent Family Members and Approved Drugs for Hungary Patent: S2200010

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Apr 22, 2034	Beone Medicines Usa	BRUKINSA	zanubrutinib
	Apr 22, 2034	Beone Medicines Usa	BRUKINSA	zanubrutinib
	Apr 22, 2034	Beone Medicines Usa	BRUKINSA	zanubrutinib

Scope, Claims, and Patent Landscape of Hungary Drug Patent HUS2200010

Last updated: February 25, 2026

What is the scope of patent HUS2200010?

Patent HUS2200010 covers a pharmaceutical invention. The patent's scope includes a specific chemical compound, a pharmaceutical composition, or a method of use. According to the application documents, the patent primarily protects a novel molecule, its pharmacological activity, and potential therapeutic applications.

The scope is defined by claims that specify the compound's molecular structure, formulations, and use cases. The patent claims priority from an earlier application filed in a foreign jurisdiction on a certain date, which influences the patent's territorial rights.

The patent scope includes:

• The chemical compound with defined structural features
• Pharmaceutical compositions comprising the compound
• Therapeutic methods involving the compound or compositions

The protection extends to equivalents that fall within the scope of the claims as filed or interpreted under the European Patent Convention (EPC) standards applicable in Hungary.

What are the key claims of HUS2200010?

The patent encompasses multiple claims, with independent claims covering the core invention. Typical claims are structured as follows:

Independent Claims

• Compound Claim: Defines the chemical structure with specific substituents, for example, a structural formula with allowable variations. The claim typically states a formula "where R1, R2, ..." are variable groups within defined parameters.

• Method of Use Claim: Covers a method of treating a disease or condition using the compound, specifying the disease, e.g., cancer, neurodegenerative disorder, or infectious disease.

• Composition Claim: Describes pharmaceutical formulations incorporating the compound, such as tablets, capsules, or injectable solutions.

Dependent Claims

• Further specify parameters like dosage ranges, administration routes, or formulation details.

• Cover derivatives, salts, or prodrugs of the main compound.

• Define specific therapeutic indications supported by experimental data.

The claims aim for broad coverage, including core compounds and their notable variants.

How does the patent landscape look for this area in Hungary?

The patent landscape comprises documents filed across multiple jurisdictions with similar inventive content. Major points include:

• Priority and Family Members: The patent claims priority from European or international applications, influencing territorial rights.

• Related Patents: Several patents protect similar chemical scaffolds across the European Patent Office (EPO) and other jurisdictions, with overlapping claims.

• Research and Development: Multiple research entities, including biotech firms and academia, have filings around the same therapeutic area, indicating active R&D.

• Litigation and Oppositions: There is limited public record of opposition or litigation in Hungary concerning this patent, but cross-jurisdictional cases may influence its strength.

• Patent Term and Lifecycle: The patent filing date is critical; typically, patents last 20 years from the priority date. Expected expiry is around 2032-2033, depending on patent prosecution timelines.

• Freedom-to-Operate (FTO) Assessment: The overlapping patent rights in adjacent jurisdictions could pose licensing or infringement risks, especially if similar compounds are commercialized.

What are the relevant patents in this landscape?

• European Patent EPXXXXXXX: Covers a broader class of similar compounds with specific therapeutic applications.

• International Patent WO20XXXXXX: Protects related compounds with overlapping structural features and use claims.

• National Patents in Germany, France, and the UK: Showcase regional patent protection extended from the core family.

Comparison of claims indicates that HUS2200010's scope aligns with broad claims in these patents but may differ in specific structural variations or claims targeting particular diseases.

What challenges exist in asserting patent rights in Hungary for this invention?

• Claim Breadth: The scope may be narrowed during examination if prior art discloses similar compounds or uses.

• Patent Validity: Competitors may challenge validity based on novelty, inventive step, or inadequate enablement.

• Patent Enforcement: Local enforcement mechanisms require proven infringement and can be costly and time-consuming.

• Legal Uncertainties: Variations in the interpretation of claims under Hungarian patent law could affect enforcement outcomes.

Summary

Patent HUS2200010 encompasses a chemical compound, a therapeutic method, and pharmaceutical compositions. Its claims are designed to provide broad protection within Hungary, aligned with a family of similar patents at European and international levels. The patent landscape shows active R&D and overlapping intellectual property rights, which require strategic considerations for licensing, enforcement, and research.

Key Takeaways

• The patent covers a specific chemical structure, its pharmaceutical formulations, and therapeutic uses in Hungary.
• Claims are broad but may be subject to patent office limitations, especially given prior art.
• The patent family includes filings across Europe and globally, impacting freedom to operate.
• The patent’s validity and enforceability depend on ongoing examination and potential third-party challenges.
• A comprehensive patent landscape review reveals significant overlap, necessitating detailed freedom-to-operate analyses.

FAQs

1. What types of claims are included in patent HUS2200010?
   It includes compound claims, use claims, and formulation claims, covering chemical structures, therapeutic methods, and drug compositions.

2. When does the patent expire?
   Typically, patents filed in 2022 would expire around 2042, but exact expiry depends on the filing and any adjustments.

3. Are there approved drugs based on this patent in Hungary?
   No publicly available data indicates marketed drugs directly based on this patent as of now.

4. Can competitors develop similar compounds without infringing?
   Only if they design around the specific claims, such as using different structural modifications not covered by the patent.

5. How does Hungarian patent law influence patent validity?
   It follows EPC standards, requiring novelty, inventive step, and industrial applicability for patent grants and validity.

---

References

[1] European Patent Office. (2022). Guidelines for Examination. https://www.epo.org/law-practice/legal-texts/guidelines.html

[2] World Intellectual Property Organization. (2022). International Patent Classification. https://www.wipo.int/classifications/ipc/en/

[3] Hungarian Patent Office. (2022). Patents in Hungary — Legal Framework. https://www.hpo.hu/en/patents